DTC
ANIP icon

Deep Track Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Deep Track Capital’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-600,000
Closed -$46.1M – 68
2026
Q1 		$46.1M Buy
600,000
+122,316
+26% +$9.55M 0.75% 34
2025
Q4 		$37.7M Buy
477,684
+27,684
+6% +$2.4M 0.67% 36
2025
Q3 		$41.2M Sell
450,000
-250,000
-36% -$20.4M 1.15% 29
2025
Q2 		$45.7M Hold
700,000
– – 1.46% 22
2025
Q1 		$46.9M Buy
700,000
+50,958
+8% +$3.04M 1.52% 20
2024
Q4 		$35.9M Buy
649,042
+144,214
+29% +$8.28M 1.34% 25
2024
Q3 		$30.1M Buy
504,828
+38,739
+8% +$2.36M 0.96% 33
2024
Q2 		$29.7M Sell
466,089
-355,912
-43% -$23.1M 0.89% 35
2024
Q1 		$56.8M Buy
822,001
+222,001
+37% +$13.4M 1.63% 25
2023
Q4 		$33.1M Buy
600,000
+200,000
+50% +$11M 1.1% 38
2023
Q3 		$23.2M Sell
400,000
-114,021
-22% -$6.58M 0.9% 35
2023
Q2 		$27.7M Buy
+514,021
New +$22.8M 1.28% 26

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deep Track Capital's ANIP Position: Q2 2026 in Review

Deep Track Capital sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 600,000 shares — an estimated $46.1M sold.

Deep Track Capital first reported a position in ANIP in Q2 2023 and held it in 12 quarters. The position peaked at $56.8M in Q1 2024. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Deep Track Capital reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Deep Track Capital sold 600,000 ANI Pharmaceuticals shares in Q2 2026, an estimated $46.1M.
  • Deep Track Capital first reported a position in ANI Pharmaceuticals in Q2 2023 and held it in 12 quarters.
  • Deep Track Capital's ANI Pharmaceuticals position peaked at $56.8M in Q1 2024.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.